Citrulline

Citrulline is a non-essential amino acid that serves as a key precursor to arginine and, subsequently, nitric oxide (NO) via the urea cycle and the arginine-NO synthase pathway. It enhances vascular function, supports muscle performance, and may benefit critically ill patients by improving hemodynamic stability and endothelial signaling.

Origin & History

Citrulline is a non-essential amino acid naturally produced in the human body through the urea cycle and is abundantly found in watermelon. It is chemically known as 2-amino-5-ureidopentanoic acid and plays a significant role in arginine metabolism and vascular function.

Historical & Cultural Context

The research does not indicate any traditional use of citrulline in historical medicine systems. Its use as a concentrated supplement appears to be a modern development, with natural presence in foods like watermelon.

Health Benefits

• May reduce postoperative pulmonary hypertension in pediatric patients, with elevated citrulline and arginine levels observed (PMID: 16798303).
• Improves ventilator-free days and survival in critically ill patients (PMID: 36620736).
• Enhances microvascular endothelial function and muscle strength (PMID: 40944179).
• Potential positive impact on lipid profile and inflammation markers like hs-CRP (PMID: 36620736).
• Improves blood flow and reduces vascular stiffness by enhancing nitric oxide production (PMID: 40944179).

How It Works

Citrulline is converted to arginine in the kidneys via argininosuccinate synthetase and argininosuccinate lyase, bypassing hepatic first-pass metabolism that limits direct arginine supplementation. Arginine then serves as the substrate for endothelial nitric oxide synthase (eNOS), catalyzing the production of nitric oxide, which activates soluble guanylate cyclase to increase cyclic GMP and promote vascular smooth muscle relaxation. Additionally, citrulline participates in the urea cycle, reducing ammonia accumulation and potentially attenuating exercise-induced fatigue by modulating AMPK and mTORC1 signaling pathways.

Scientific Research

Clinical trials have shown citrulline's potential benefits in various health conditions. Notable studies include a pediatric study on postoperative pulmonary hypertension (PMID: 16798303) and an RCT on critical illness and mechanical ventilation (PMID: 36620736). A meta-analysis reviewed the heterogeneity in trial designs for blood pressure interventions (PMID: PMC11053694).

Clinical Summary

A study in pediatric cardiac surgery patients (PMID: 16798303) found that citrulline supplementation significantly elevated plasma citrulline and arginine levels, reducing the incidence of postoperative pulmonary hypertension. A randomized controlled trial in critically ill adults (PMID: 36620736) demonstrated that citrulline supplementation improved ventilator-free days and 28-day survival compared to placebo. Smaller trials and meta-analyses in healthy adults and athletes report improvements in microvascular endothelial function and muscle strength, particularly with L-citrulline doses of 3–8 g/day or citrulline malate at 6–8 g/day pre-exercise. Overall evidence is moderate-to-promising but larger, well-powered RCTs are still needed, especially for performance and longevity endpoints.

Nutritional Profile

Citrulline (C₆H₁₃N₃O₃, MW 175.19 g/mol) is a non-essential alpha-amino acid and key intermediate in the urea cycle. It is not one of the 20 standard proteinogenic amino acids and is therefore not incorporated into proteins during translation. Key nutritional and biochemical details: • **Endogenous synthesis**: Produced primarily in enterocytes of the small intestine from glutamine and proline via ornithine; also generated as a byproduct of nitric oxide synthase (NOS) converting arginine to nitric oxide (NO). • **Dietary sources**: The richest natural dietary source is watermelon (Citrullus lanatus), containing approximately 1.1–4.7 mg/g fresh weight (flesh) and up to 24 mg/g in rind; also found in smaller amounts in cucumbers, pumpkins, bitter melon, and other cucurbits. • **Supplement forms**: Commonly available as L-citrulline (free-form) or citrulline malate (typically 2:1 ratio of citrulline to malic acid); typical supplemental doses range from 3–8 g/day of L-citrulline or 6–8 g/day of citrulline malate. • **Bioactive role**: Serves as the most efficient oral precursor to L-arginine; oral citrulline bypasses hepatic first-pass metabolism (unlike oral arginine, which is substantially catabolized by hepatic arginase), resulting in superior plasma arginine elevation — approximately 1.5–2× greater increase in plasma arginine compared to equimolar oral arginine supplementation. • **Bioavailability**: Oral bioavailability is high (>80%); absorbed in the small intestine, transported to the kidneys where it is converted to arginine via argininosuccinate synthase (ASS) and argininosuccinate lyase (ASL). Peak plasma citrulline levels occur approximately 40–60 minutes post-ingestion. • **Caloric/macronutrient contribution**: Negligible caloric value at supplemental doses (~4 kcal/g as an amino acid, but doses are small); contains no vitamins, minerals, fiber, or fat. Each molecule provides 3 nitrogen atoms (23.99% nitrogen by mass), contributing to nitrogen balance. • **Plasma reference range**: Normal circulating plasma citrulline levels are approximately 20–40 µmol/L in healthy adults; levels below 10 µmol/L may indicate intestinal failure or reduced enterocyte mass. • **Related bioactive metabolites**: Directly feeds into arginine → NO pathway, supporting nitric oxide-dependent vasodilation; also contributes to polyamine synthesis and creatine biosynthesis indirectly via arginine. • **No known essential micronutrient content**: Pure citrulline contains no vitamins or minerals; watermelon-derived citrulline co-occurs with lycopene, vitamin C (~8.1 mg/100g), potassium (~112 mg/100g), and other phytonutrients.

Preparation & Dosage

Clinically studied dosage ranges include 1.9 g/m² per dose in postoperative settings, daily supplementation over 7 days in critically ill patients, and up to 24 g/day in tolerance studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-arginine, watermelon extract, nitric oxide boosters, beetroot powder, taurine

Safety & Interactions

Citrulline is generally well tolerated at doses up to 15 g/day, with the most commonly reported side effects being mild gastrointestinal discomfort, nausea, or diarrhea at higher doses. Because citrulline raises nitric oxide and arginine levels, it may potentiate the hypotensive effects of PDE5 inhibitors (e.g., sildenafil, tadalafil) and nitrate-based medications, and concurrent use should be approached cautiously. Individuals with rare urea cycle disorders, particularly argininosuccinate synthetase deficiency, should avoid citrulline supplementation without medical supervision. Safety data in pregnancy and lactation are insufficient, so use during these periods is not recommended without physician guidance.